# PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC

> **NCT07697859** · — · RECRUITING · sponsor: **Fudan University** · enrollment: 354 (estimated)

## Conditions studied

- Esophageal Squamous Cell Carcinoma (ESCC)

## Interventions

- **OTHER:** Two arms adopt local intervention administered at distinct timings.

## Key facts

- **NCT ID:** NCT07697859
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-15
- **Primary completion:** 2029-07-15
- **Final completion:** 2031-07-15
- **Target enrollment:** 354 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697859, "PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*